WHO ICTRP trial
An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects…
NL-OMON36684 · Overview of Medical Research in the Netherlands (NL-OMON)
Key facts
| Trial ID | NL-OMON36684 |
|---|---|
| Public title | An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects with Crohn s Disease (CCX114644) |
| Scientific title | An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects with Crohn s Disease (CCX114644) - CCX114644 |
| Primary sponsor | GlaxoSmithKline |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Study type | Interventional |
| Phase | 3 |
| Countries | Australia;Belgium;Canada;Czechia;Denmark;France;Germany;Japan;Netherlands ;Norway;Sweden;United Kingdom;United States of America |
| Conditions | Crohn's disease;10017969;Crohn's disease |
| Interventions | Treatment with GSK1605786A. ;chemokine antagonist;Crohn's disease;GSK1605786A;longterm effects |
| Registration date | Jul 29, 2011 |
| Target size | 30 |
| Secondary IDs | 2010-022384-35;clinicaltrials.gov, registratienummer n.n.b.;NL34541.018.10 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: